Quantcast
Last updated on April 21, 2014 at 9:29 EDT

Latest Arthur D. Levinson Stories

2013-10-24 08:34:16

Display Features Recently Acquired Objects from Genentech WASHINGTON, Oct. 24, 2013 /PRNewswire/ -- The Smithsonian's National Museum of American History chronicles the story of biotechnology and its impact on society in a new showcase display, "The Birth of Biotech," which opens Oct. 25. The display, located in a first floor History Highlights Case, will explore the science and industry behind the first major product of the biotech boom--recombinant human insulin. Made by...

Google Spinoff Seeks To Extend Human Lifespan
2013-09-19 08:21:31

[ Watch the Video: Google Has Its Sights Set On Your Lifespan ] redOrbit Staff & Wire Reports - Your Universe Online Google has launched an independent healthcare company to develop new technologies that fight age-related illnesses and extend the human lifespan. The new venture, dubbed Calico, will be run by former Genentech chief executive Arthur Levinson, who will also be an investor. “Illness and aging affect all our families... from the decreased mobility and mental...

2013-02-20 04:22:12

SAN FRANCISCO, February 20, 2013 /PRNewswire/ -- 11 Inaugural winners receive US$3 million each for Groundbreaking Achievements in Life Science Research Art Levinson, Sergey Brin, Anne Wojcicki, Mark Zuckerberg, Priscilla Chan and Yuri Milner announced today the launch of the Breakthrough Prize in Life Sciences ("Breakthrough Prize"), recognizing excellence in research aimed at curing intractable diseases and extending human life. The...

2009-10-21 08:00:00

SOUTH SAN FRANCISCO, Calif., Oct. 21 /PRNewswire/ -- NGM Biopharmaceuticals, Inc. (NGM), a private company dedicated to the discovery and development of novel biotherapeutics for the treatment of Type 2 diabetes and other metabolic diseases, today announced that Arthur D. Levinson, Ph.D., the Chairman of Genentech's Board of Directors, has been appointed to NGM's Board of Directors. Under Dr. Levinson's leadership as Chairman and Chief Executive Officer from 1995 to 2009, Genentech...

2009-10-12 14:15:00

SANTA MONICA, Calif., Oct. 12 /PRNewswire-USNewswire/ -- Arthur D. Levinson, a member of both Google and Apple's boards, acted correctly in resigning from Google's board, Consumer Watchdog said today. "We're pleased that Arthur Levinson finally realized that serving on both Google's and Apple's boards was untenable," said John M. Simpson, consumer advocate with Consumer Watchdog. "It took too long, but he finally did the right thing."' The nonpartisan, nonprofit advocacy group had...

2009-08-03 14:36:00

SANTA MONICA, Calif., Aug. 3 /PRNewswire-USNewswire/ -- Genentech Board Chairman Arthur D. Levinson should quit as a director of either Internet giant Google or Apple to avoid antitrust violations, Consumer Watchdog said today, following the resignation of Eric Schmidt from the Apple board. The call from the nonprofit, nonpartisan consumer group came after the announcement that Google Chairman and Chief Executive Eric Schmidt, who held the same dual role, was stepping down from Apple's...

2009-03-12 01:00:00

-- Roche intends to acquire all outstanding shares of Genentech for US$95.00 per share in cash -- Research and early development to operate as an independent center; South San Francisco site to become headquarters of combined U.S. commercial operations; Genentech's unique culture to be maintained -- Innovation will be enhanced through a diversity of research approaches and sharing of IP, technologies, partnerships and other key assets -- Transaction expected to be EPS accretive in the...

2008-07-21 18:00:21

By Steve Johnson, San Jose Mercury News, Calif. Jul. 21--In a blockbuster move that could bring an end to the corporate independence of a Bay Area biotechnology legend, Swiss drug giant Roche is proposing to take complete control of South San Francisco-based Genentech for nearly $44 billion. Roche, headquartered in Basel, Switzerland, already owns 56 percent of Genentech, the world's biggest biotech company in terms of stock value and second biggest in revenue to Amgen of Thousand Oaks....